1. Testing the theory of immune selection in cancers that break the rules of transplantation

   • Ariberto Fassati
   • N. Avrion Mitchison

   Perspectives Open access 22 December 2009 Pages: 643 - 651

2. Intratumoral CD8⁺ T/FOXP3⁺ cell ratio is a predictive marker for survival in patients with colorectal cancer

   • Hiroyuki Suzuki
   • Nobuhito Chikazawa
   • Mitsuo Katano

   Original Article 12 November 2009 Pages: 653 - 661

   

3. Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

   • James L. Gulley
   • Philip M. Arlen
   • Jeffrey Schlom

   Original Article 05 November 2009 Pages: 663 - 674

   

4. Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of Shh

   • Akio Yamasaki
   • Chizu Kameda
   • Mitsuo Katano

   Original Article 28 October 2009 Pages: 675 - 686

   

5. Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting

   • Matthias May
   • Sabine Brookman-May
   • Manfred Johannsen

   Original Article 30 October 2009 Pages: 687 - 695

   

6. Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2′-deoxycytidine

   • Irina Daurkin
   • Evgeniy Eruslanov
   • Sergei Kusmartsev

   Original Article 31 October 2009 Pages: 697 - 706

   

7. A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vector

   • Weijun Zhang
   • Tong Zhang
   • Edward J. Usherwood

   Original Article 17 November 2009 Pages: 707 - 713

   

8. Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy

   • Eftychia Lekka
   • Angelos D. Gritzapis
   • Constantin N. Baxevanis

   Original Article 11 November 2009 Pages: 715 - 727

   

9. TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model

   • Nasreen Vohra
   • Monique Verhaegen
   • Shari Pilon-Thomas

   Original Article 17 November 2009 Pages: 729 - 736

   

10. Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin

    • Robert Sarnovsky
    • Tara Tendler
    • David J. FitzGerald

    Original Article 29 November 2009 Pages: 737 - 746

    

11. Topoisomerase II alpha as a universal tumor antigen: antitumor immunity in murine tumor models and H-2K^b-restricted T cell epitope

    • Jung-Sun Park
    • Hye-Sung Kim
    • Tai-Gyu Kim

    Original Paper 20 November 2009 Pages: 747 - 757

    

12. EphA2-derived peptide vaccine with amphiphilic poly(γ-glutamic acid) nanoparticles elicits an anti-tumor effect against mouse liver tumor

    • Shinjiro Yamaguchi
    • Tomohide Tatsumi
    • Norio Hayashi

    Original Article 27 November 2009 Pages: 759 - 767

    

13. Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma

    • Miki Tongu
    • Nanae Harashima
    • Mamoru Harada

    Original Article 26 November 2009 Pages: 769 - 777

    

14. Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function

    • Chang-Xuan You
    • Yong Liu
    • Paul L. Hermonat

    Original Article 29 November 2009 Pages: 779 - 787

    

15. Activation of innate immunity to reduce lung metastases in breast cancer

    • Julie L. Jordan
    • A. Nowak
    • T. D. G. Lee

    Original Article 03 December 2009 Pages: 789 - 797

    

16. Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3

    • Cornelia L. Trimble
    • Shiwen Peng
    • T. C. Wu

    Short Communication 13 December 2009 Pages: 799 - 803